CRISPR Screening: From target selection to patient stratification

Sign Up:

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.



Already Registered? Click Here

CRISPR Screening: From target selection to patient stratification

May 14, 2019
8:00 am PT, 11:00 am ET, 17:00 CET



In a remarkably short time since its development, high-throughput CRISPR screening has revolutionized functional genomics and drug discovery. CRISPR screening applications and technology adaptations have increased and evolved, now becoming a core engine for both novel drug discovery and for driving new therapies to the patient more quickly and precisely. Recent developments have now enabled researchers to bring these approaches to primary human immune cells, where there is a high potential for the discovery of new cell therapy strategies.
In this webinar, Eric Shifrut, postdoctoral fellow at UCSF, and Benedict Cross, Head of Functional Genomic Screening at Horizon, will present the principles, strategies and experimental outcomes of CRISPR screening, including screening in primary T cells.


A live Q&A session will follow the presentations, offering you a chance to pose questions to our expert panelists.


Eric Shifrut, PhD
Postdoctoral Scholar Microbiology and Immunology
University of California, San Francisco
View Biography
Benedict Cross, PhD
Head of Functional Genomic Screening
Horizon Discovery
View Biography
Kevin Davies, PhD
Executive Editor, The CRISPR Journal
View Biography